Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 1||UN / IM|
Administered by: Unknown Purchased by: Unknown
Symptoms: Acute disseminated encephalomyelitis, Diplopia, Headache, Nasopharyngitis, Nuclear magnetic resonance imaging abnormal, Paresis
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data: Magnetic resonance imaging, 18Dec08, hyperintense enhancement in the caudal salivary nucleus left
CDC 'Split Type': WAES0901USA02992
Write-up:Information has been received from Health Authority on 15-JAN-2009 (reference #2009-00031) concerning a 15 year old female adolescent who was intramuscularly vaccinated with the first 0.5 ml dose of GARDASIL (batch number not reported, site of administration not reported) in October 2008. In November 2008 she received the second 0.5 ml dose of GARDASIL, IM. From 07-DEC-2008 until 11-DEC-2008 she developed headache. On 11-DEC-2008 she noted a diplopia, which was progressive and she had symptoms of common cold. A paresis of the left abducent nerve was diagnosed. On 18-DEC-2008 an MRI showed hyperintense enhancement in the caudal salivary nucleus left. An acute disseminated encephalitis was diagnosed. Other business partner numbers include E2009-00291. No further information is available.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166